Acotec Scientific Holdings Limited announced that on March 23, 2023, the Group received the registration approvals from the Food and Drug Administration of Thailand for Vericor, a peripheral support catheter designed to enhance access to peripheral vessels. Vericor is used together with guidewires to recanalize chronic total occlusion (CTO) lesions and below-the-knee ("BTK") lesions and to reduce the difficulty of performing surgeries on complex lesions and BTK lesions. The Company will carry out marketing activities when appropriate.
Acotec Scientific Holdings Limited
Equities
6669
KYG0096M1096
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.45 HKD | -3.01% | -1.98% | -42.82% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.82% | 259M | |
+73.46% | 12.41B | |
-15.61% | 8.23B | |
+3.88% | 6.46B | |
+14.69% | 5.5B | |
-5.53% | 5.33B | |
+42.58% | 5.1B | |
-32.61% | 2.54B | |
+10.80% | 1.99B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- 6669 Stock
- News Acotec Scientific Holdings Limited
- Acotec Scientific Holdings Limited Announces Approval for Vericor by the Food and Drug Administration of Thailand